Educational Session to Provide Update on Recent Progress in Treatment of ‘Extensive-Stage’ SCLC
Fred GebhartDrs. Hidehito Horinouchi and Stephen Liu will chair the session, which will explore multiple advances driving survival gains, including antibody-drug conjugates, bispecific T-cell engagers, and targeted therapies. Read more
New Strategic Plan to be Unveiled at IASLC Business Meeting
Erin JungmeyerMembers are invited to join the meeting and learn about the new plan, which will guide the association for the next 5 years. Read more
Opening Plenary Session Examines Treatment Inequities, Humanitarian Toll of Lung Cancer
Cody HoltIn addition to thought-provoking keynotes from Her Royal Highness Princess Dina Mired and Dr. Gary Rodin, the official kickoff of #WCLC23 included a lively celebration of the meeting’s host city. Read more
Novel Immunochemotherapy / Anti-Angiogenesis Combo Shows Best Survival to Date for ES-SCLC
Fred GebhartInvestigator Dr. Ying Cheng says study results support the use of immunochemotherapy plus anti-angiogenesis as a new treatment option in a difficult-to-treat patient population. Read more
Make time to visit the Exhibit Hall this evening to talk with poster presenters about their research. Read more
Presidential Symposium to Highlight Late-Breaking, Practice-Changing Research
Fred GebhartThe symposium also marks a change in IASLC leadership as Dr. Heather Wakelee will deliver the final Presidential Address of her term. Read more
Plenary 4 Offers Early Look at 9th Edition of TNM Staging Classification for Thoracic Cancers
Fred GebhartIASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura joins Drs. Valerie Rusch and Enrico Ruffini to review updates in lung cancer, mesothelioma, and thymic cancer. Read more
Annual Award Recognizes Importance of Multidisciplinary Teams
Erin JungmeyerThe IASLC Cancer Care Team award highlights the teamwork required to provide the best possible patient care. Read more
Since WCLC 2022, JTO, led by Dr. Alex A. Adjei, has continued to increase its impact factor, and JTO CRR has welcomed a new Editor-in-Chief, Dr. Emily Stone. Read more
Her Royal Highness Princess Dina Mired of Jordan Sees Challenges and Progress in Global Cancer Care
Cody HoltIn an exclusive interview, Princess Dina talks with ILCN about her passion for improving equitable access to cancer care, tobacco control, prevention, and more. Read more